Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
9.39
+0.51 (5.74%)
Nov 21, 2024, 2:39 PM EST - Market open
Emergent BioSolutions Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -208.8 | -760.5 | -211.6 | 219.5 | 305.8 | 54.5 | Upgrade
|
| Depreciation & Amortization | 112.4 | 125.1 | 130.6 | 123.8 | 114.5 | 110.7 | Upgrade
|
| Other Amortization | 10.9 | 21.3 | 4.1 | 4.1 | 3.5 | 3 | Upgrade
|
| Loss (Gain) From Sale of Assets | -17.2 | -74.2 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 27.2 | 524.9 | 19.4 | 41.7 | 29 | 12 | Upgrade
|
| Stock-Based Compensation | 17.7 | 23.1 | 45.1 | 42.4 | 51.8 | 26.7 | Upgrade
|
| Other Operating Activities | 11.7 | 4.3 | -19.6 | 33.7 | 22.8 | 23.5 | Upgrade
|
| Change in Accounts Receivable | 89.6 | -21.6 | 118.1 | -16.2 | 27.5 | -8.2 | Upgrade
|
| Change in Inventory | -9.9 | 0.6 | -57.1 | -66.6 | -66.9 | -16.7 | Upgrade
|
| Change in Accounts Payable | -29.9 | 10.6 | -14 | -1.6 | 28.3 | 16.5 | Upgrade
|
| Change in Unearned Revenue | -14.7 | 5.9 | 9.6 | -31.8 | 11.2 | 16 | Upgrade
|
| Change in Income Taxes | 13.9 | -16.2 | 28.7 | -31.3 | 6 | - | Upgrade
|
| Change in Other Net Operating Assets | 167.8 | -49.6 | -87.4 | 2.5 | 3.4 | -50 | Upgrade
|
| Operating Cash Flow | 170.7 | -206.3 | -34.1 | 320.2 | 536.9 | 188 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -40.36% | 185.59% | 349.76% | Upgrade
|
| Capital Expenditures | -32.6 | -51.6 | -115.8 | -224.1 | -141.9 | -86.9 | Upgrade
|
| Sale of Property, Plant & Equipment | 7.6 | - | - | - | - | - | Upgrade
|
| Divestitures | 110.2 | 270.2 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -6.3 | -243.7 | - | -10 | -10 | Upgrade
|
| Other Investing Activities | - | - | -21.8 | - | - | - | Upgrade
|
| Investing Cash Flow | 85.2 | 212.3 | -381.3 | -224.1 | -151.9 | -96.9 | Upgrade
|
| Long-Term Debt Issued | - | 20 | 598 | - | 450 | 130 | Upgrade
|
| Long-Term Debt Repaid | - | -563.4 | -33.8 | -35.9 | -387.1 | -116.3 | Upgrade
|
| Total Debt Repaid | -498.3 | -563.4 | -33.8 | -35.9 | -387.1 | -116.3 | Upgrade
|
| Net Debt Issued (Repaid) | -194.3 | -543.4 | 564.2 | -35.9 | 62.9 | 13.7 | Upgrade
|
| Issuance of Common Stock | 10.7 | 10.2 | 5 | 15.9 | 31.6 | 8.2 | Upgrade
|
| Repurchase of Common Stock | -1 | -2.5 | -88 | -119.8 | -13.8 | -7.4 | Upgrade
|
| Other Financing Activities | -1.2 | - | - | -1.2 | -11.2 | -50.4 | Upgrade
|
| Financing Cash Flow | -185.8 | -535.7 | 481.2 | -141 | 69.5 | -35.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.5 | -1.2 | 0.5 | -0.3 | -1 | 0.4 | Upgrade
|
| Net Cash Flow | 68.6 | -530.9 | 66.3 | -45.2 | 453.5 | 55.6 | Upgrade
|
| Free Cash Flow | 138.1 | -257.9 | -149.9 | 96.1 | 395 | 101.1 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -75.67% | 290.70% | - | Upgrade
|
| Free Cash Flow Margin | 12.27% | -24.58% | -13.41% | 5.42% | 25.04% | 9.14% | Upgrade
|
| Free Cash Flow Per Share | 2.63 | -5.04 | -2.99 | 1.78 | 7.34 | 1.93 | Upgrade
|
| Cash Interest Paid | 67.6 | 68.3 | 33 | 30.4 | 21 | 34.5 | Upgrade
|
| Cash Income Tax Paid | 50 | 52.8 | 6.2 | 71.6 | 109.3 | 30.8 | Upgrade
|
| Levered Free Cash Flow | 89.59 | -103.41 | -203.13 | 39.19 | 393.94 | 113.51 | Upgrade
|
| Unlevered Free Cash Flow | 127.38 | -69.78 | -183.91 | 56.65 | 410 | 134.51 | Upgrade
|
| Change in Net Working Capital | -101 | 40.2 | -68.2 | 126.7 | -83.6 | 0.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.